Clinical studies recruiting near Pessac

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
Phase 1/Phase 2 · CHU de Bordeaux - Hôpital Haut-Lévêque - Centre François Mag · The Lymphoma Academic Research Organisation · NCT07018752 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · CHU Bordeaux Haut-Leveque · Pfizer · NCT06758401 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Centre Hospitalier Universitaire de Bordeaux - Hopital Haut- · Miltenyi Biomedicine GmbH · NCT04844866 Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NA · Hopital Haut-Leveque - Chu - Pessac · University Hospital, Lille · NCT03728049 Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer
Phase 2 · Groupe SUD-Haut-Lévêque - Centre Hospitalier Universitaire d · Center Eugene Marquis · NCT05265208 Metabolic Fluid Responsiveness in Children
Phase N/A · Hôpital Cardiologique Haut Lévêque - CHU de Bordeaux · University Hospital, Bordeaux · NCT07255469 A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
Phase 3 · CHU Bordeaux - Hôpital Haut Leveque-Site Number : 2500003 · Sanofi · NCT07190196 Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2 · Hôpital de Haut-Lévêque · Hospices Civils de Lyon · NCT03593317 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · CHU Bordeaux · Hoffmann-La Roche · NCT06793215 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · CHU Bordeaux Haut-Leveque · Bristol-Myers Squibb · NCT07291076 Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
Phase 2 · Hématologie clinique et thérapie cellulaire Hôpital Haut-Lév · University Hospital, Clermont-Ferrand · NCT04935684 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Centre Hospitalier Universitaire de Bordeaux - Hopital Haut · Amgen · NCT07037433 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · CHU Bordeaux Haut-Leveque · Eli Lilly and Company · NCT07415044 Transplantation After Complete Response In Patients With T-cell Lymphoma
NA · Chu de Bordeaux - Hopital Haut-Leveque · Hospices Civils de Lyon · NCT05444712 Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character o
NA · CHU de Bordeaux - service de médecine interne · University Hospital, Bordeaux · NCT04800458 Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete
NA · CHU Haut Lévêque · Institut Curie · NCT04731610 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · CHU Bordeaux Haut-Leveque · Eli Lilly and Company · NCT06890598 Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse
Phase 2 · Chu de Bordeaux · The Lymphoma Academic Research Organisation · NCT06271057 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Centre Hospitalier Universitaire (CHU) de Bordeaux · Regeneron Pharmaceuticals · NCT06091865 Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy
Phase N/A · CHU Bordeaux · University Hospital, Bordeaux · NCT06416397 New Clinical Decision Support Score Based on Steroid Hormone Profiling in the Diagnosis of MACS
Phase N/A · Hôpital du Haut-Lévêque · University Hospital, Bordeaux · NCT07352527 Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
Phase N/A · Hopital Haut Leveque · Institut National de la Santé Et de la Recherche Médicale, F · NCT06711666 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · CHU Bordeaux Haut-Leveque ( Site 1106) · Merck Sharp & Dohme LLC · NCT06077760 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0091 · Celgene · NCT05519085 DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refrac
Phase 2 · CHU Bordeaux- Hôpital Haut Lévêque · ImmunoVaccine Technologies, Inc. (IMV Inc.) · NCT04920617 FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Phase 2 · Centre Francois Magendie · Centre Leon Berard · NCT06393816 A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 2 · CHU de Bordeaux - Hospital Haut-Leveque · Janssen Research & Development, LLC · NCT04634552 A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulc
Phase 4 · CHU Bordeaux - Hôpital Haut Lévêque · Groupe d'Etude Therapeutique des Affections Inflammatoires D · NCT04183608 Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
Phase 2 · Chu Bordeaux · University Hospital, Lille · NCT05572229 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Centre Hospitalier Universitaire de Bordeaux · Kura Oncology, Inc. · NCT07007312

Look up another city

Look up another condition